Precision treatment in colorectal cancer: Now and the future
Until recently, a one‐drug‐fits‐all model was applied to every patient diagnosed with the same condition. But not every condition is the same, and this has led to many cases of ineffective treatment. Pharmacogenetics is increasingly used to stratify patients for precision medicine treatments, for in...
Main Author: | Tung On Yau |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-10-01
|
Series: | JGH Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/jgh3.12153 |
Similar Items
-
Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal Cancer
by: Hans Urban, et al.
Published: (2020-10-01) -
Ophthalmic complications of targeted therapies: a review
by: Deepti Sharma
Published: (2017-01-01) -
Expressions and Their Significances of Vascular Endothelial Growth Factor-C mRNA and Epidermal Growth Factor Receptor mRNA in Non-small Cell Lung Cancer Tissues and Lymph Node Tissues
by: Yan GUAN, et al.
Published: (2010-12-01) -
An immunohistochemical study of EGFR expression in colorectal cancer and its correlation with lymph nodes status and tumor grade
by: Mojgan Mokhtari, et al.
Published: (2012-01-01) -
Advances in diagnosis and treatment of malignant pleural mesothelioma
by: Giorgio Vittorio Scagliotti, et al.
Published: (2011-12-01)